• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆 IL-6 浓度与慢性荨麻疹患者的临床疾病活动度和血清 C 反应蛋白浓度相关。

Plasma IL-6 concentration correlates with clinical disease activity and serum C-reactive protein concentration in chronic urticaria patients.

机构信息

Clinical Department of Internal Diseases, Allergology and Clinical Immunology, Medical University of Silesia, Katowice, Poland.

出版信息

Clin Exp Allergy. 2011 Oct;41(10):1386-91. doi: 10.1111/j.1365-2222.2011.03789.x. Epub 2011 Jun 6.

DOI:10.1111/j.1365-2222.2011.03789.x
PMID:21645137
Abstract

BACKGROUND

Our previous study was the first to demonstrate enhanced plasma IL-6 concentrations in chronic urticaria (CU). It is known that C-reactive protein (CRP) is a sensitive marker of an underlying systemic inflammation, triggered mainly as a response to IL-6.

OBJECTIVE

To evaluate plasma IL-6 concentration in CU patients relating to the clinical disease activity and serum CRP concentration.

METHODS

Serum CRP and plasma IL-6 concentrations were measured in 58 CU patients and 30 healthy subjects. Ten CU patients were evaluated twice, during the active period as well as upon the spontaneous clinical remission of the disease. CU activity was assessed with the use of the symptom scores recommended by EAACI/GALEN/EDF guidelines.

RESULTS

IL-6 and CRP concentrations were significantly increased in CU patients as compared with the healthy subjects, whereas they decreased remarkably upon the spontaneous remission. IL-6 concentration was associated with weekly urticaria activity scores and also significant differences were found between patients showing different degrees of urticarial activity. Significant correlation was observed between IL-6 and CRP concentrations.

CONCLUSIONS AND CLINICAL RELEVANCE

This study reinforces evidence that, apart from a local cutaneous inflammation, CU is associated with a systemic inflammatory response. Such acute-phase response is manifested by increased circulating IL-6, which varies along with CRP changes and may be related to the urticarial activity.

摘要

背景

我们之前的研究首次表明,慢性荨麻疹(CU)患者的血浆白细胞介素 6(IL-6)浓度升高。已知 C 反应蛋白(CRP)是潜在全身炎症的敏感标志物,主要作为对 IL-6 的反应而触发。

目的

评估 CU 患者的血浆 IL-6 浓度与临床疾病活动度和血清 CRP 浓度的关系。

方法

测量了 58 例 CU 患者和 30 例健康对照者的血清 CRP 和血浆 IL-6 浓度。10 例 CU 患者在活动期和疾病自发临床缓解时进行了两次评估。使用 EAACI/GALEN/EDF 指南推荐的症状评分来评估 CU 活动度。

结果

与健康对照组相比,CU 患者的 IL-6 和 CRP 浓度显著升高,而在疾病自发缓解时显著降低。IL-6 浓度与每周荨麻疹活动评分相关,且在具有不同程度荨麻疹活动的患者之间也存在显著差异。IL-6 和 CRP 浓度之间存在显著相关性。

结论和临床相关性

这项研究进一步证实了除了局部皮肤炎症外,CU 还与全身炎症反应有关。这种急性期反应表现为循环 IL-6 增加,其变化与 CRP 变化一致,可能与荨麻疹活动度有关。

相似文献

1
Plasma IL-6 concentration correlates with clinical disease activity and serum C-reactive protein concentration in chronic urticaria patients.血浆 IL-6 浓度与慢性荨麻疹患者的临床疾病活动度和血清 C 反应蛋白浓度相关。
Clin Exp Allergy. 2011 Oct;41(10):1386-91. doi: 10.1111/j.1365-2222.2011.03789.x. Epub 2011 Jun 6.
2
Markers of systemic inflammation in delayed pressure urticaria.迟发性压力性荨麻疹的全身性炎症标志物。
Int J Dermatol. 2013 Mar;52(3):309-10. doi: 10.1111/j.1365-4632.2011.05330.x. Epub 2012 Nov 1.
3
Coagulation/fibrinolysis and inflammation markers are associated with disease activity in patients with chronic urticaria.凝血/纤溶和炎症标志物与慢性荨麻疹患者的疾病活动度相关。
Allergy. 2010 May;65(5):649-56. doi: 10.1111/j.1398-9995.2009.02222.x. Epub 2009 Oct 20.
4
Acute-phase response in chronic urticaria.慢性荨麻疹的急性期反应。
J Eur Acad Dermatol Venereol. 2012 Jun;26(6):665-72. doi: 10.1111/j.1468-3083.2011.04366.x. Epub 2011 Nov 25.
5
Plasma levels of matrix metalloproteinase-9 in chronic urticaria patients correlate with disease severity and C-reactive protein but not with circulating histamine-releasing factors.慢性荨麻疹患者的基质金属蛋白酶-9 血浆水平与疾病严重程度和 C 反应蛋白相关,但与循环组胺释放因子无关。
Clin Exp Allergy. 2010 Jun;40(6):875-81. doi: 10.1111/j.1365-2222.2010.03473.x. Epub 2010 Mar 4.
6
Plasma concentration of interleukin 6 (IL-6), and its relationship with circulating concentration of dehydroepiandrosterone sulfate (DHEA-S) in patients with chronic idiopathic urticaria.慢性特发性荨麻疹患者白细胞介素6(IL-6)的血浆浓度及其与硫酸脱氢表雄酮(DHEA-S)循环浓度的关系。
Cytokine. 2007 Aug;39(2):142-6. doi: 10.1016/j.cyto.2007.06.008. Epub 2007 Sep 10.
7
Elevated plasma il-8 concentration is related to severity of systemic inflammation in chronic spontaneous urticaria.血浆白细胞介素-8浓度升高与慢性自发性荨麻疹全身炎症的严重程度相关。
J Biol Regul Homeost Agents. 2017 Oct-Dec;31(4):957-961.
8
The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.C反应蛋白作为稳定期慢性阻塞性肺疾病全身炎症标志物的价值
Eur J Intern Med. 2008 Mar;19(2):104-8. doi: 10.1016/j.ejim.2007.04.026.
9
Analysis of procalcitonin and CRP concentrations in serum of patients with chronic spontaneous urticaria.慢性自发性荨麻疹患者血清降钙素原和 C 反应蛋白浓度分析。
Inflamm Res. 2013 Mar;62(3):309-12. doi: 10.1007/s00011-012-0580-1. Epub 2012 Dec 4.
10
Serum eotaxin levels in patients with chronic spontaneous urticaria.慢性自发性荨麻疹患者的血清嗜酸性粒细胞趋化蛋白水平
Eur Ann Allergy Clin Immunol. 2012 Oct;44(5):188-92.

引用本文的文献

1
Treatment of indolent systemic mastocytosis with sarilumab is not supported in a randomized trial.一项随机试验不支持使用萨瑞鲁单抗治疗惰性系统性肥大细胞增多症。
J Allergy Clin Immunol Glob. 2025 May 21;4(3):100498. doi: 10.1016/j.jacig.2025.100498. eCollection 2025 Aug.
2
Unveiling the immunopharmacological mechanisms of Danggui Yinzi (DGYZ) in treating chronic urticaria: insights from network pharmacology and experimental validation.揭示当归饮子治疗慢性荨麻疹的免疫药理机制:基于网络药理学和实验验证的见解
Chin Med. 2025 Jun 9;20(1):81. doi: 10.1186/s13020-025-01137-7.
3
Using virtual patient cohorts to uncover immune response differences in cancer and immunosuppressed COVID-19 patients.
利用虚拟患者队列揭示癌症患者和免疫抑制的新冠肺炎患者的免疫反应差异。
PLoS Comput Biol. 2025 Jun 9;21(6):e1013170. doi: 10.1371/journal.pcbi.1013170.
4
Utility of serum biomarkers in real-world practice for predicting response to omalizumab therapy in patients with chronic spontaneous urticaria.血清生物标志物在慢性自发性荨麻疹患者中预测奥马珠单抗治疗反应的真实世界实践中的效用。
J Allergy Clin Immunol Glob. 2024 Dec 12;4(1):100386. doi: 10.1016/j.jacig.2024.100386. eCollection 2025 Feb.
5
Key differences between chronic inducible and spontaneous urticaria.慢性诱导性荨麻疹与自发性荨麻疹之间的关键差异。
Front Allergy. 2024 Oct 17;5:1487831. doi: 10.3389/falgy.2024.1487831. eCollection 2024.
6
The relationship between serum transglutaminase-2 levels and the severity of chronic spontaneous urticaria.血清转谷氨酰胺酶-2 水平与慢性自发性荨麻疹严重程度的关系。
Clin Exp Med. 2024 Jul 22;24(1):164. doi: 10.1007/s10238-024-01422-z.
7
Immunopathogenesis of urticaria: a clinical perspective on histamine and cytokine involvement.荨麻疹的免疫发病机制:组胺和细胞因子参与的临床观点。
Inflamm Res. 2024 May;73(5):877-896. doi: 10.1007/s00011-024-01869-6. Epub 2024 Mar 31.
8
[Which augmentation and trigger factors are relevant in urticaria?].[哪些增敏和触发因素与荨麻疹相关?]
Dermatologie (Heidelb). 2024 Apr;75(4):295-302. doi: 10.1007/s00105-024-05306-x. Epub 2024 Feb 12.
9
Cytokine Profiles of Chronic Urticaria Patients and The Effect of Omalizumab Treatment.慢性荨麻疹患者的细胞因子谱及奥马珠单抗治疗的效果
Dermatol Pract Concept. 2023 Oct 1;13(4):e2023272. doi: 10.5826/dpc.1304a272.
10
Involvement of and Genes and TNF signaling pathways in mast cell activation and pathogenesis of chronic spontaneous urticaria.和 TNF 信号通路在肥大细胞激活和慢性自发性荨麻疹发病机制中的作用。
Front Immunol. 2023 Aug 14;14:1247432. doi: 10.3389/fimmu.2023.1247432. eCollection 2023.